-
公开(公告)号:US20110071126A1
公开(公告)日:2011-03-24
申请号:US12723137
申请日:2010-03-12
申请人: Salvacion CACATIAN , David A. CLAREMON , Lawrence W. DILLARD , Klaus FUCHS , Niklas HEINE , Lanqi JIA , Katerina LEFTHERIS , Brian McKEEVER , Angel MORALES-RAMOS , Suresh B. SINGH , Shankar VENKATRAMAN , Guosheng WU , Zhongren WU , Zhenrong XU , Jing YUAN , Yajun ZHENG
发明人: Salvacion CACATIAN , David A. CLAREMON , Lawrence W. DILLARD , Klaus FUCHS , Niklas HEINE , Lanqi JIA , Katerina LEFTHERIS , Brian McKEEVER , Angel MORALES-RAMOS , Suresh B. SINGH , Shankar VENKATRAMAN , Guosheng WU , Zhongren WU , Zhenrong XU , Jing YUAN , Yajun ZHENG
IPC分类号: A61K31/4245 , C07D271/12 , C07D498/10 , C07D239/70 , A61K31/527 , C07D235/02 , A61K31/4184 , C07D413/10 , A61K31/501 , A61K31/497 , C07D417/10 , C07D401/10 , A61K31/4439 , C07D409/10 , C07D417/06 , C07D403/06 , A61K31/498 , C07D273/04 , A61K31/5395 , C07D279/08 , A61K31/547 , C07D513/10 , A61P27/06 , A61P25/28 , A61P25/00
CPC分类号: C07D271/12 , C07D233/46 , C07D235/02 , C07D239/70 , C07D277/60 , C07D279/08 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D487/10 , C07D491/10 , C07D493/20 , C07D495/10 , C07D498/10 , C07D513/10
摘要: The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
摘要翻译: 本发明涉及由以下结构式表示的化合物或其药学上可接受的盐。 还描述了化合物的药物组合物和使用方法。
-
公开(公告)号:US20140200223A1
公开(公告)日:2014-07-17
申请号:US14132877
申请日:2013-12-18
申请人: Salvacion Cacatian , David A. Claremon , Lawrence Wayne Dillard , Klaus Fuchs , Niklas Heine , Lanqi Jia , Katerina Leftheris , Brian Mckeever , Angel Morales-Ramos , Suresh B. Singh , Shankar Venkatraman , Guosheng Wu , Zhongren Wu , Zhenrong Xu , Jing Yuan , Yajun Zheng
发明人: Salvacion Cacatian , David A. Claremon , Lawrence Wayne Dillard , Klaus Fuchs , Niklas Heine , Lanqi Jia , Katerina Leftheris , Brian Mckeever , Angel Morales-Ramos , Suresh B. Singh , Shankar Venkatraman , Guosheng Wu , Zhongren Wu , Zhenrong Xu , Jing Yuan , Yajun Zheng
IPC分类号: C07D271/12 , C07D239/70 , C07D403/06 , C07D498/10 , C07D417/06 , C07D405/06 , C07D413/04 , C07D233/46
CPC分类号: C07D271/12 , C07D233/46 , C07D235/02 , C07D239/70 , C07D277/60 , C07D279/08 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D487/10 , C07D491/10 , C07D493/20 , C07D495/10 , C07D498/10 , C07D513/10
摘要: The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
摘要翻译: 本发明涉及由以下结构式表示的化合物或其药学上可接受的盐。 还描述了化合物的药物组合物和使用方法。
-
公开(公告)号:US08633212B2
公开(公告)日:2014-01-21
申请号:US12723137
申请日:2010-03-12
申请人: Salvacion Cacatian , David A. Claremon , Lawrence W. Dillard , Klaus Fuchs , Niklas Heine , Lanqi Jia , Katerina Leftheris , Brian McKeever , Angel Morales-Ramos , Suresh B. Singh , Shankar Venkatraman , Guosheng Wu , Zhongren Wu , Zhenrong Xu , Jing Yuan , Yajun Zheng
发明人: Salvacion Cacatian , David A. Claremon , Lawrence W. Dillard , Klaus Fuchs , Niklas Heine , Lanqi Jia , Katerina Leftheris , Brian McKeever , Angel Morales-Ramos , Suresh B. Singh , Shankar Venkatraman , Guosheng Wu , Zhongren Wu , Zhenrong Xu , Jing Yuan , Yajun Zheng
IPC分类号: A61K31/405 , A61K31/415 , A61K31/41 , A61K31/40 , C07D237/00 , C07D271/10 , C07D487/10 , C07D209/54
CPC分类号: C07D271/12 , C07D233/46 , C07D235/02 , C07D239/70 , C07D277/60 , C07D279/08 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D487/10 , C07D491/10 , C07D493/20 , C07D495/10 , C07D498/10 , C07D513/10
摘要: The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
摘要翻译: 本发明涉及由以下结构式表示的化合物或其药学上可接受的盐。 还描述了化合物的药物组合物和使用方法。
-
-